Methylprednisolone attenuates lipopolysaccharide-induced Fractalkine expression in kidney of Lupus-prone MRL/lpr mice through the NF-kappaB pathway
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2369
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Methylprednisolone attenuates lipopolysaccharide-induced Fractalkine expression in kidney of Lupus-prone MRL/lpr mice through the NF-kappaB pathway ; volume:16 ; number:1 ; day:27 ; month:8 ; year:2015 ; pages:1-8 ; date:12.2015
BMC nephrology ; 16, Heft 1 (27.8.2015), 1-8, 12.2015
- Urheber
-
You, Yanwu
- Beteiligte Personen und Organisationen
-
Qin, Yueqiu
Lin, Xu
Yang, Fafen
Li, Jun
Sooranna, Suren R.
Pinhu, Liao
SpringerLink (Online service)
- DOI
-
10.1186/s12882-015-0145-y
- URN
-
urn:nbn:de:1111-201611059698
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- You, Yanwu
- Qin, Yueqiu
- Lin, Xu
- Yang, Fafen
- Li, Jun
- Sooranna, Suren R.
- Pinhu, Liao
- SpringerLink (Online service)
Ähnliche Objekte (12)
Funktion von CD3+-B220+-T-Zellen aus MRL-lpr-lpr-Mäusen
The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus-prone MRL/lpr mice
hUC-MSC transplantation therapy effects on lupus-prone MRL/lpr mice at early disease stages
Immunomodulatory effects of atorvastatin on MRL/lpr mice
ALW peptide ameliorates lupus nephritis in MRL/lpr mice
Fecal microbiota from MRL/lpr mice exacerbates pristane-induced lupus
Untersuchung des Einflusses von BM 41 209 (Nachfolgesubstanz von Imexon) auf das MRL-lpr/lpr-Mausmodell
Proteasominhibition als Therapie zur Behandlung der Lupusnephritis im MRL-lpr-Mausmodell
The Fas receptor in normal and lupus-prone, MRL-lpr/lpr mice : analysis of the genetic defect in lpr mice and the expression of the apoptosis-inducing Fas receptor in lymphocytes of normal and autoimmune mouse strains
Analysis of C4 and the C4 binding protein in the MRL/lpr mouse
Activation of BZW1 by CEBPB in macrophages promotes eIF2α phosphorylation-mediated metabolic reprogramming and endoplasmic reticulum stress in MRL/lpr lupus-prone mice
Triple‐threat quantitative multiplexed plasma proteomics analysis on immune complex disease MRL‐lpr mice
Funktion von CD3+-B220+-T-Zellen aus MRL-lpr-lpr-Mäusen
The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus-prone MRL/lpr mice
hUC-MSC transplantation therapy effects on lupus-prone MRL/lpr mice at early disease stages
Immunomodulatory effects of atorvastatin on MRL/lpr mice
ALW peptide ameliorates lupus nephritis in MRL/lpr mice
Fecal microbiota from MRL/lpr mice exacerbates pristane-induced lupus
Untersuchung des Einflusses von BM 41 209 (Nachfolgesubstanz von Imexon) auf das MRL-lpr/lpr-Mausmodell
Proteasominhibition als Therapie zur Behandlung der Lupusnephritis im MRL-lpr-Mausmodell
The Fas receptor in normal and lupus-prone, MRL-lpr/lpr mice : analysis of the genetic defect in lpr mice and the expression of the apoptosis-inducing Fas receptor in lymphocytes of normal and autoimmune mouse strains
Analysis of C4 and the C4 binding protein in the MRL/lpr mouse
Activation of BZW1 by CEBPB in macrophages promotes eIF2α phosphorylation-mediated metabolic reprogramming and endoplasmic reticulum stress in MRL/lpr lupus-prone mice
Triple‐threat quantitative multiplexed plasma proteomics analysis on immune complex disease MRL‐lpr mice
Funktion von CD3+-B220+-T-Zellen aus MRL-lpr-lpr-Mäusen
The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus-prone MRL/lpr mice
hUC-MSC transplantation therapy effects on lupus-prone MRL/lpr mice at early disease stages
Immunomodulatory effects of atorvastatin on MRL/lpr mice
ALW peptide ameliorates lupus nephritis in MRL/lpr mice
Fecal microbiota from MRL/lpr mice exacerbates pristane-induced lupus
Untersuchung des Einflusses von BM 41 209 (Nachfolgesubstanz von Imexon) auf das MRL-lpr/lpr-Mausmodell
Proteasominhibition als Therapie zur Behandlung der Lupusnephritis im MRL-lpr-Mausmodell
The Fas receptor in normal and lupus-prone, MRL-lpr/lpr mice : analysis of the genetic defect in lpr mice and the expression of the apoptosis-inducing Fas receptor in lymphocytes of normal and autoimmune mouse strains
Analysis of C4 and the C4 binding protein in the MRL/lpr mouse
Activation of BZW1 by CEBPB in macrophages promotes eIF2α phosphorylation-mediated metabolic reprogramming and endoplasmic reticulum stress in MRL/lpr lupus-prone mice